Skip to content

News & Resources

Featured Stories

Siren Biotechnology Awarded $4M in Grant Funding from the California Institute for Regenerative Medicine (CIRM) Read More
Posted on 10.4.23
2023 All-In Summit – A discussion on the future of gene therapy
Posted on 8.24.23
Developing universal AAV immuno-gene therapy for oncology
Fierce Biotech
Posted on 5.18.23
New biotech Siren calls for gene therapy and cancer to ‘get into the weeds together’
Biopharma Dive
Posted on 5.17.23
Siren emerges from stealth with plans to marry gene therapy to cancer immunotherapy
San Francisco Business Times
Posted on 5.17.23
Nicole Paulk’s Siren Bio is building a gene therapy delivery vehicle against cancer
Genetic Engineering & Biotechnology News
Posted on 5.17.23
ASGCT News: Siren Biotechnology Hails Universal Gene Therapy for Oncology
Stat
Posted on 5.17.23
A new startup looks to turn the workhorse of gene therapy against cancer
San Francisco Business Times
Posted on 3.2.23
Nicole Paulk is named one of the Bay Area’s next generation of life science researchers
Wired logo
Posted on 12.5.22
Insights from Nicole Paulk on the latest gene therapy for hemophilia B
The Economist
Posted on 8.25.22
Siren’s Founder & CEO, Nicole Paulk, speaks on pricing and access for gene therapies